Natco Pharma Limited Press Release Sep 28 2026

Ref: Earlier intimation dated 25th August, 2026 regarding the investment in eGenesis, Inc. With reference to the above cited subject, NATCO Pharma Limited ("NATCO") has decided to increase its investment in eGenesis, Inc. from the previously disclosed amount of US$14.00 million to US$16.70 million through its wholly owned subsidiaries. In addition, there has been a change in the subsidiaries parti